|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBSCO_ocn733777874 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
110630s2011 dcua ob 100 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d E7B
|d AZU
|d NATAP
|d IDEBK
|d OCLCQ
|d WVH
|d OCLCQ
|d ZMC
|d OCLCQ
|d NLGGC
|d OCLCO
|d YDXCP
|d MMU
|d COF
|d CDX
|d CDS
|d OCLCQ
|d EBLCP
|d DEBSZ
|d OCLCQ
|d NKT
|d OCLCQ
|d AZK
|d OCLCF
|d OCLCA
|d TOA
|d AGLDB
|d MOR
|d PIFAG
|d ZCU
|d OCLCQ
|d MERUC
|d OCLCQ
|d NJR
|d OCLCO
|d OCLCA
|d U3W
|d OCLCA
|d BUF
|d OCLCO
|d OCLCQ
|d KIJ
|d OCLCO
|d OCL
|d STF
|d WRM
|d VNS
|d OCLCO
|d OCLCQ
|d VTS
|d COCUF
|d NRAMU
|d EZ9
|d ICG
|d MERER
|d CUY
|d AU@
|d OCLCQ
|d OCLCO
|d OCLCQ
|d DKC
|d OCLCO
|d OCLCQ
|d M8D
|d HS0
|d UWK
|d UKBTH
|d LIP
|d OCLCQ
|d OCLCA
|d UKCRE
|d LVT
|d OCLCO
|d OCLCQ
|d SFB
|d OCLCO
|d OCLCA
|d OCLCQ
|d OCLCO
|d DST
|d OCLCO
|d OCLCQ
|d OCL
|d OCLCO
|
019 |
|
|
|a 704436490
|a 726823493
|a 727945896
|a 923283111
|a 961552730
|a 962622132
|a 988531684
|a 992110377
|a 1011843862
|a 1022038658
|a 1027336314
|a 1027344927
|a 1028795755
|a 1037929448
|a 1038648009
|a 1045444130
|a 1047574291
|a 1058360831
|a 1097138584
|a 1109095971
|a 1110405504
|a 1112973419
|a 1119419252
|a 1119436603
|a 1119510039
|a 1120913284
|a 1153544383
|a 1159662249
|a 1162396832
|a 1204380476
|a 1204393533
|a 1227629172
|a 1229747877
|a 1241946254
|a 1259175141
|a 1290030594
|a 1300471590
|a 1303343066
|a 1303436081
|a 1306570855
|
020 |
|
|
|a 9780309161831
|q (electronic bk.)
|
020 |
|
|
|a 0309161835
|q (electronic bk.)
|
020 |
|
|
|a 1283019132
|
020 |
|
|
|a 9781283019132
|
020 |
|
|
|a 9786613019134
|
020 |
|
|
|a 6613019135
|
020 |
|
|
|z 0309161827
|
020 |
|
|
|z 9780309161824
|
020 |
|
|
|a 0309209617
|
020 |
|
|
|a 9780309209618
|
024 |
8 |
|
|a 9786613019134
|
029 |
1 |
|
|a AU@
|b 000053277477
|
029 |
1 |
|
|a DEBBG
|b BV043104882
|
029 |
1 |
|
|a DEBBG
|b BV044109181
|
029 |
1 |
|
|a DEBSZ
|b 42162406X
|
029 |
1 |
|
|a DEBSZ
|b 452578000
|
029 |
1 |
|
|a GBVCP
|b 803600399
|
029 |
1 |
|
|a HEBIS
|b 299821331
|
029 |
1 |
|
|a NZ1
|b 14256145
|
035 |
|
|
|a (OCoLC)733777874
|z (OCoLC)704436490
|z (OCoLC)726823493
|z (OCoLC)727945896
|z (OCoLC)923283111
|z (OCoLC)961552730
|z (OCoLC)962622132
|z (OCoLC)988531684
|z (OCoLC)992110377
|z (OCoLC)1011843862
|z (OCoLC)1022038658
|z (OCoLC)1027336314
|z (OCoLC)1027344927
|z (OCoLC)1028795755
|z (OCoLC)1037929448
|z (OCoLC)1038648009
|z (OCoLC)1045444130
|z (OCoLC)1047574291
|z (OCoLC)1058360831
|z (OCoLC)1097138584
|z (OCoLC)1109095971
|z (OCoLC)1110405504
|z (OCoLC)1112973419
|z (OCoLC)1119419252
|z (OCoLC)1119436603
|z (OCoLC)1119510039
|z (OCoLC)1120913284
|z (OCoLC)1153544383
|z (OCoLC)1159662249
|z (OCoLC)1162396832
|z (OCoLC)1204380476
|z (OCoLC)1204393533
|z (OCoLC)1227629172
|z (OCoLC)1229747877
|z (OCoLC)1241946254
|z (OCoLC)1259175141
|z (OCoLC)1290030594
|z (OCoLC)1300471590
|z (OCoLC)1303343066
|z (OCoLC)1303436081
|z (OCoLC)1306570855
|
043 |
|
|
|a n-us---
|
050 |
|
4 |
|a RB155.8
|b .E88 2011eb
|
060 |
|
4 |
|a 2011 E-283
|
060 |
|
4 |
|a QZ 50
|
072 |
|
7 |
|a SCI
|x 029000
|2 bisacsh
|
082 |
0 |
4 |
|a 576.5072
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Product Development :
|b Workshop Summary /
|c Steve Olson and Adam C. Berger, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies.
|
260 |
|
|
|a Washington, D.C. :
|b National Academies Press,
|c 2011.
|
300 |
|
|
|a 1 online resource (74 pages) :
|b color illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references.
|
505 |
0 |
0 |
|t Introduction --
|t A lesson about precompetitive collaboration --
|t Requisites for successful precompetitive collaboration --
|t Frameworks for collaboration --
|t The use of biospecimens in precompetitive collaborations --
|t Ethical challenges in the use of biospecimens --
|t Toward developing a cultural, legal, and behavioral framework for precompetitive collaboration.
|
520 |
|
|
|a "Despite the many basic research discoveries in genetics, relatively few gene-based treatments, drugs, or preventative measures have been developed. One way to bridge this gap may be for industry, academia, and government to develop partnerships that share resources while distributing risk. However, intellectual property protections and other barriers can inhibit collaborative efforts. The Institute of Medicine held a workshop on July 22, 2010, to explore these issues and develop solutions."--Publisher's description
|
588 |
0 |
|
|a Print version record.
|
546 |
|
|
|a English.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Genomics
|x Research
|z United States
|v Congresses.
|
650 |
|
0 |
|a Gene therapy
|x Research
|z United States
|v Congresses.
|
650 |
|
0 |
|a Academic-industrial collaboration
|z United States
|v Congresses.
|
650 |
|
0 |
|a Gene therapy.
|
650 |
|
0 |
|a Genomics.
|
650 |
|
0 |
|a Pharmacogenetics
|v Congresses.
|
650 |
|
0 |
|a Drug development
|v Congresses.
|
650 |
|
0 |
|a Genomics
|v Congresses.
|
650 |
1 |
2 |
|a Genetic Therapy
|
650 |
1 |
2 |
|a Genetic Research
|x economics
|
650 |
2 |
2 |
|a Genomics
|
650 |
2 |
2 |
|a Public-Private Sector Partnerships
|
651 |
|
2 |
|a United States
|
650 |
|
6 |
|a Pharmacogénétique
|v Congrès.
|
650 |
|
6 |
|a Médicaments
|x Développement
|v Congrès.
|
650 |
|
6 |
|a Génomique
|v Congrès.
|
650 |
|
6 |
|a Génomique
|x Recherche
|z États-Unis
|v Congrès.
|
650 |
|
6 |
|a Thérapie génique
|x Recherche
|z États-Unis
|v Congrès.
|
650 |
|
6 |
|a Collaboration université-industrie
|z États-Unis
|v Congrès.
|
650 |
|
6 |
|a Thérapie génique.
|
650 |
|
6 |
|a Génomique.
|
650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Genetics & Genomics.
|2 bisacsh
|
650 |
|
7 |
|a Pharmacogenetics
|2 fast
|
650 |
|
7 |
|a Genomics
|2 fast
|
650 |
|
7 |
|a Gene therapy
|2 fast
|
650 |
|
7 |
|a Drug development
|2 fast
|
650 |
|
7 |
|a Academic-industrial collaboration
|2 fast
|
650 |
|
7 |
|a Gene therapy
|x Research
|2 fast
|
651 |
|
7 |
|a United States
|2 fast
|
655 |
|
2 |
|a Congress
|
655 |
|
7 |
|a proceedings (reports)
|2 aat
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
655 |
|
7 |
|a Actes de congrès.
|2 rvmgf
|
700 |
1 |
|
|a Olson, Steve,
|d 1956-
|
700 |
1 |
|
|a Berger, Adam C.
|
710 |
2 |
|
|a Institute of Medicine (U.S.).
|b Roundtable on Translating Genomic-Based Research for Health.
|
776 |
0 |
8 |
|i Print version:
|t Establishing precompetitive collaborations to stimulate genomics-driven product development.
|d Washington, D.C. : National Academies Press, 2011
|z 9780309161824
|w (OCoLC)707536665
|
830 |
|
0 |
|a Online access: NCBI NCBI Bookshelf.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=359517
|z Texto completo
|
938 |
|
|
|a Coutts Information Services
|b COUT
|n 17508044
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3378741
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10454959
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 359517
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n 301913
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 6011522
|
994 |
|
|
|a 92
|b IZTAP
|